Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis. [electronic resource]
- International journal of cancer Nov 2010
- 2279-91 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't